Lisa Ann Cloutier, APRN | |
250 Main St Ste 22d, Windsor Locks, CT 06096-1904 | |
(860) 463-9535 | |
(860) 831-1033 |
Full Name | Lisa Ann Cloutier |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Psychiatric/mental Health |
Location | 250 Main St Ste 22d, Windsor Locks, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003868092 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Lisa Ann Cloutier, APRN 4 Brownstone Rd, East Granby, CT 06026-9705 Ph: (860) 651-9159 | Lisa Ann Cloutier, APRN 250 Main St Ste 22d, Windsor Locks, CT 06096-1904 Ph: (860) 463-9535 |
News Archive
Thickness of the cornea, the thin, transparent layer covering the eye, may be an important factor in considering treatment options for patients with glaucoma, according to an article appearing in the September issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.
Group of biomedical engineers from biotech company Gruppo Fos Lithuania together with researchers at Kaunas University of Technology and Lithuanian University of Health Sciences have patented technology for advanced health monitoring of stroke survivors.
Erythropoietin (Epo) is actually a medication for anaemia. According to researchers at the Max Planck Institute of Experimental Medicine in Göttingen, the doping agent Epo could also be effective against Covid-19.
Acclarent, Inc., part of the Johnson & Johnson Medical Devices Companies and a leader in developing minimally-invasive Ear, Nose & Throat technologies, today announced the U.S. commercial launch of TruDi, a real-time, three-dimensional navigation system for ENT procedures performed in the operating room and surgeon office.
The Center will conduct research into Type 2 diabetes, among other diseases, and will acquire the capacities and resources to establish itself as one of the leading international research centers in the world. With 885 million Danish kroner (approx. 160 million US Dollars) from the Novo Nordisk Foundation, a team of 5 leading research scientists will be headhunted by the University to oversee "The Novo Nordisk Foundation Center for Basic Metabolic Research".
› Verified 5 days ago